Correlation of Cytokine Release Syndrome With Prognosis After Chimeric Antigen Receptor T Cell Therapy: Analysis of 54 Patients With Relapsed or Refractory Multiple Myeloma

Although chimeric antigen receptor T (CAR-T) cell therapy has proven to be effective in treating relapsed or refractory multiple myeloma (R/R MM), the severity of cytokine release syndrome (CRS) can affect patient survival and the risk factors for CRS remain an intractable issue. We enrolled 54 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue, Zhao, Lina, Wang, Jing, Yao, Yue, Wang, Jiaojiao, Ji, Shengwei, Hua, Tian, Wang, Shiyuan, Cheng, Hai, Shi, Ming, Li, Zhenyu, Zeng, Lingyu, Zheng, Junnian, Xu, Kailin, Cao, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092941/
https://www.ncbi.nlm.nih.gov/pubmed/35572513
http://dx.doi.org/10.3389/fimmu.2022.814548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092941/
https://www.ncbi.nlm.nih.gov/pubmed/35572513
http://dx.doi.org/10.3389/fimmu.2022.814548

Ejemplares similares